Galea Therapeutics

Our molecule reverts Fatty Liver Disease by reducing liver fat by 41%, fat biosynthesis by 35%, liver cell apoptosis by 89% and excessive food intake by 48%.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Madrid, Spain
  • Currency EUR
  • Founded October 2018
  • Employees 3
  • Incorporation Type C-corp
  • Website galeatherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free